drugset
drugset / Trial / NCT00057486

Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients

NCT00057486 ↗

Phase 1/2 Terminated 2 enrolled National Institute of Allergy and Infectious Diseases (NIAID)
RandomizedParallel-groupDouble-blindTreatment

Summary

There is no proven effective treatment for chronic diarrhea caused by the parasite Cryptosporidium in advanced AIDS. This trial will test the safety of interleukin-12 (IL-12) as part of a combination therapy for this parasite.

Timeline

Start
1997-09
Primary completion
2005-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject interleukin-12 Protein / enzyme biologic 110 ng/ml Other
Subject interleukin-12 Protein / enzyme biologic 300 ng/ml Other

Indications

HIV infectious disease cryptosporidiosis